Winterbourn, C. C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82–83, 969–974 (1995).
Galy, B., Conrad, M. & Muckenthaler, M. Mechanisms controlling cellular and systemic iron homeostasis. Nat. Rev. Mol. Cell Biol. 25, 133–155 (2024).
Weinberg, E. D. Nutritional immunity: host’s attempt to withhold iron from microbial invaders. JAMA 231, 39–41 (1975).
Murdoch, C. C. & Skaar, E. P. Nutritional immunity: the battle for nutrient metals at the host–pathogen interface. Nat. Rev. Microbiol. 20, 657–670 (2022).
Caza, M. & Kronstad, J. Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front. Cell. Infect. Microbiol. 3, 80 (2013).
Nairz, M., Schroll, A., Sonnweber, T. & Weiss, G. The struggle for iron—a metal at the host-pathogen interface. Cell. Microbiol. 12, 1691–1702 (2010).
Chen, G. Y. & Ayres, J. S. Beyond tug-of-war: iron metabolism in cooperative host-microbe interactions. PLoS Pathog. 16, e1008698 (2020).
Marchetti, M. et al. Iron metabolism at the interface between host and pathogen: from nutritional immunity to antibacterial development. Int. J. Mol. Sci. 21, 2145 (2020).
Nairz, M. & Weiss, G. Iron in infection and immunity. Mol. Aspects Med. 75, 100864 (2020).
Celis, A. I. & Relman, D. A. Competitors versus collaborators: micronutrient processing by pathogenic and commensal human-associated gut bacteria. Mol. Cell 78, 570–576 (2020).
Mayneris-Perxachs, J., Moreno-Navarrete, J. M. & Fernández-Real, J. M. The role of iron in host–microbiota crosstalk and its effects on systemic glucose metabolism. Nat. Rev. Endocrinol. 18, 683–698 (2022).
Jaeggi, T. et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut 64, 731–742 (2015).
Constante, M., Fragoso, G., Calvé, A., Samba-Mondonga, M. & Santos, M. M. Dietary heme induces gut dysbiosis, aggravates colitis and potentiates the development of adenomas in mice. Front. Microbiol. 8, 1809 (2017).
Constante, M., Fragoso, G., Lupien-Meilleur, J., Calvé, A. & Santos, M. M. Iron supplements modulate colon microbiota composition and potentiate the protective effects of probiotics in dextran sodium sulfate-induced colitis. Inflamm. Bowel Dis. 23, 753–766 (2017).
Mahalhal, A. et al. Oral iron exacerbates colitis and influences the intestinal microbiome. PLoS ONE 13, e0202460 (2018).
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017).
Zimmermann, M. B. et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Côte d’Ivoire. Am. J. Clin. Nutr. 92, 1406–1415 (2010).
Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740–748 (2016).
Shayeghi, M. et al. Identification of an intestinal heme transporter. Cell 122, 789–801 (2005).
Laftah, A. H. et al. Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1). Br. J. Nutr. 101, 1150–1156 (2008).
Donovan, A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191–200 (2005).
Schwartz, A. J. et al. Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload. J. Clin. Invest. 129, 336–348 (2019).
Nemeth, E. & Ganz, T. Hepcidin and iron in health and disease. Annu. Rev. Med. 74, 261–277 (2023).
Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093 (2004).
Ganz, T. Anemia of inflammation. N. Engl. J. Med. 381, 1148–1157 (2019).
Mottelson, M. et al. Iron, hemochromatosis genotypes, and risk of infections: a cohort study of 142, 188 general population individuals. Blood 144, 693–707 (2024).
Ding, C., Festa, R. A., Sun, T.-S. & Wang, Z.-Y. Iron and copper as virulence modulators in human fungal pathogens. Mol. Microbiol. 93, 10–23 (2014).
Porcheron, G. & Dozois, C. M. Interplay between iron homeostasis and virulence: fur and RyhB as major regulators of bacterial pathogenicity. Vet. Microbiol. 179, 2–14 (2015).
Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015).
Stefanova, D. et al. Hepcidin protects against lethal Escherichia coli sepsis in mice Inoculated with isolates from septic patients. Infect. Immun. 86, e00253-18 (2018).
Michels, K. R. et al. Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia. JCI Insight 2, e92002 (2017).
Monteith, A. J. & Skaar, E. P. The impact of metal availability on immune function during infection. Trends Endocrinol. Metab. 32, 916–928 (2021).
Rodriguez, R. et al. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect. Immun. 82, 745–752 (2014).
Nakashige, T. G., Zhang, B., Krebs, C. & Nolan, E. M. Human calprotectin is an iron-sequestering host-defense protein. Nat. Chem. Biol. 11, 765–771 (2015).
Wang, J. et al. Multi-metal restriction by calprotectin impacts de novo flavin biosynthesis in Acinetobacter baumannii. Cell Chem. Biol. 26, 745–755.e7 (2019).
Zygiel, E. M., Nelson, C. E., Brewer, L. K., Oglesby-Sherrouse, A. G. & Nolan, E. M. The human innate immune protein calprotectin induces iron starvation responses in Pseudomonas aeruginosa. J. Biol. Chem. 294, 3549–3562 (2019).
Jaberi, S. A. et al. Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed. Pharmacother. 142, 112002 (2021).
Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921 (2004).
Bachman, M. A., Lenio, S., Schmidt, L., Oyler, J. E. & Weiser, J. N. Interaction of lipocalin 2, transferrin and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. mBio 3, e00224-11 (2012).
Sakamoto, K. et al. IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections. Sci. Immunol. 2, eaai8371 (2017).
Woodman, T. et al. Effects of lactoferrin on neonatal pathogens and Bifidobacterium breve in human breast milk. PLoS ONE 13, e0201819 (2018).
Vega-Bautista, A. et al. The impact of lactoferrin on the growth of intestinal inhabitant bacteria. Int. J. Mol. Sci. 20, 4707 (2019).
Vidal, S. M., Malo, D., Vogan, K., Skamene, E. & Gros, P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469–485 (1993).
Bessman, N. J. et al. Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science 368, 186–189 (2020).
Willers, M. et al. S100A8 and S100A9 are important for postnatal development of gut microbiota and immune system in mice and infants. Gastroenterology 159, 2130–2145.e5 (2020).
Singh, V. et al. Microbiota-inducible innate immune siderophore binding protein lipocalin 2 is critical for intestinal homeostasis. Cell. Mol. Gastroenterol. Hepatol. 2, 482–498.e6 (2016).
Klüber, P. et al. Depletion of lipocalin 2 (LCN2) in mice leads to dysbiosis and persistent colonization with segmented filamentous bacteria. Int. J. Mol. Sci. 22, 13156 (2021).
Moschen, A. R. et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe 19, 455–469 (2016).
Mastromarino, P. et al. Correlation between lactoferrin and beneficial microbiota in breast milk and infant’s feces. BioMetals 27, 1077–1086 (2014).
Kramer, J., Özkaya, Ö. & Kümmerli, R. Bacterial siderophores in community and host interactions. Nat. Rev. Microbiol. 18, 152–163 (2020).
Raffatellu, M. et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5, 476–486 (2009).
Vatanen, T. et al. Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat. Microbiol. 4, 470–479 (2019).
Byun, H., Jung, I.-J., Chen, J., Larios Valencia, J. & Zhu, J. Siderophore piracy enhances Vibrio cholerae environmental survival and pathogenesis. Microbiology 166, 1038–1046 (2020).
Báumler, A. J. & Hantke, K. Ferrioxamine uptake in Yersinia enterocolitica: characterization of the receptor protein FoxA. Mol. Microbiol. 6, 1309–1321 (1992).
Kingsley, R. A. et al. Ferrioxamine-mediated iron(III) utilization by Salmonella enterica. Appl. Environ. Microbiol. 65, 1610–1618 (1999).
Santus, W. et al. Mycobiota and diet-derived fungal xenosiderophores promote Salmonella gastrointestinal colonization. Nat. Microbiol. 7, 2025–2038 (2022).
Zhu, W. et al. Xenosiderophore utilization promotes bacteroides thetaiotaomicron resilience during colitis. Cell Host Microbe 27, 376–388.e8 (2020).
Spiga, L. et al. Iron acquisition by a commensal bacterium modifies host nutritional immunity during Salmonella infection. Cell Host Microbe https://doi.org/10.1016/j.chom.2023.08.018 (2023).
Chassaing, B. et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS ONE 7, e44328 (2012).
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H. & Adolph, T. E. Calprotectin: from biomarker to biological function. Gut 70, 1978–1988 (2021).
Hurrell, R. & Egli, I. Iron bioavailability and dietary reference values. Am. J. Clin. Nutr. 91, 1461S–1467S (2010).
Al Nabhani, Z. et al. A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity 50, 1276–1288.e5 (2019).
Li, H. et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat. Commun. 6, 8292 (2015).
Deriu, E. et al. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14, 26–37 (2013).
Sassone-Corsi, M. et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature 540, 280–283 (2016).
Vazquez-Gutierrez, P., De Wouters, T., Werder, J., Chassard, C. & Lacroix, C. High iron-sequestrating Bifidobacteria inhibit enteropathogen growth and adhesion to intestinal epithelial cells in vitro. Front. Microbiol. 7, 1480 (2016).
Song, L. et al. Trojan horselike T6SS effector TepC mediates both interference competition and exploitative competition. ISME J. 18, wrad028 (2024).
Gómez-Garzón, C., Barrick, J. E. & Payne, S. M. Disentangling the evolutionary history of Feo, the major ferrous iron transport system in bacteria. mBio 13, e03512–e03521 (2022).
Deshpande, A., Olaitan, A. O., Mckelvey, A. M., Rutherford, J. T. & Hurdle, J. G. The ferrous iron transporter FeoB1 is essential for Clostridioides difficile toxin production and pathogenesis in mice. Preprint at https://doi.org/10.1101/2022.03.03.482942 (2022).
Bairwa, G., Hee Jung, W. & Kronstad, J. W. Iron acquisition in fungal pathogens of humans. Metallomics 9, 215–227 (2017).
Roy, U. & Kornitzer, D. Heme-iron acquisition in fungi. Curr. Opin. Microbiol. 52, 77–83 (2019).
Wan, T. et al. Structural basis of non-canonical transcriptional regulation by the σA-bound iron-sulfur protein WhiB1 in M. tuberculosis. Nucleic Acids Res. 48, 501–516 (2020).
El-Lababidi, R. M. & Rizk, J. G. Cefiderocol: a siderophore cephalosporin. Ann. Pharmacother. 54, 1215–1231 (2020).
Wu, S.-E. et al. Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature 586, 108–112 (2020).
González, A. et al. Identification of the key excreted molecule by Lactobacillus fermentum related to host iron absorption. Food Chem. 228, 374–380 (2017).
Bouglé, D. et al. Influence of short-chain fatty acids on iron absorption by proximal colon. Scand. J. Gastroenterol. 37, 1008–1011 (2002).
Hoppe, M., Önning, G., Berggren, A. & Hulthén, L. Probiotic strain Lactobacillus plantarum 299v increases iron absorption from an iron-supplemented fruit drink: a double-isotope cross-over single-blind study in women of reproductive age. Br. J. Nutr. 114, 1195–1202 (2015).
Zhang, F., Yung, K. K. L. & KongYeung, C. Effects of common prebiotics on iron status and production of colonic short-chain fatty acids in anemic rats. Food Sci. Hum. Wellness 10, 327–334 (2021).
Agrizzi Verediano, T., Agarwal, N., Juste Contin Gomes, M., Martino, H. S. D. & Tako, E. Effects of dietary fiber on intestinal iron absorption, and physiological status: a systematic review of in vivo and clinical studies. Crit. Rev. Food Sci. Nutr. 63, 9017–9032 (2022).
Zhang, D. et al. The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow. Cell Stem Cell 29, 232–247.e7 (2022).
Zhu, L. et al. Microbiota-assisted iron uptake promotes immune tolerance in the intestine. Nat. Commun. 14, 2790 (2023).
Qi, B. & Han, M. Microbial siderophore enterobactin promotes mitochondrial iron uptake and development of the host via interaction with ATP synthase. Cell 175, 571–582.e11 (2018).
Kot, E. & Bezkorovainy, A. Binding of ferric iron to the cell walls and membranes of Bifidobacterium thermophilum: effect of free radicals. J. Agric. Food Chem. 47, 4606–4610 (1999).
Ghadimi, D. et al. Regulation of hepcidin/iron-signalling pathway interactions by commensal bifidobateria plays an important role for the inhibition of metaflammation-related biomarkers. Immunobiology 225, 151874 (2020).
Das, N. K. et al. Microbial metabolite signaling is required for systemic iron homeostasis. Cell Metab. 31, 115–130.e6 (2020).
Parmanand, B. A. et al. A decrease in iron availability to human gut microbiome reduces the growth of potentially pathogenic gut bacteria; an in vitro colonic fermentation study. J. Nutr. Biochem. 67, 20–27 (2019).
Yamaki, J., Chawla, S., Tong, S., Lozada, K. A. & Yang, S. Iron effects on Clostridioides difficile toxin production and antimicrobial susceptibilities. Antibiotics 11, 537 (2022).
Pi, H. et al. Clostridioides difficile ferrosome organelles combat nutritional immunity. Nature 623, 1009–1016 (2023).
Dostal, A. et al. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children. Br. J. Nutr. 112, 547–556 (2014).
Baldi, A. et al. Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial. Nat. Commun. 15, 8640 (2024).
Pereira, D. I. A. et al. Dietary iron depletion at weaning imprints low microbiome diversity and this is not recovered with oral nano Fe(III). MicrobiologyOpen 4, 12–27 (2015).
Celis, A. I., Relman, D. A. & Huang, K. C. The impact of iron and heme availability on the healthy human gut microbiome in vivo and in vitro. Cell Chem. Biol. 30, 110–126.e3 (2023).
Dostal, A. et al. Iron modulates butyrate production by a child gut microbiota in vitro. mBio 6, e01453-15 (2015).
Dostal, A. et al. Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in Rats123. J. Nutr. 142, 271–277 (2012).
Frost, J. N. et al. Plasma iron controls neutrophil production and function. Sci. Adv. 8, eabq5384 (2022).
Jabara, H. H. et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat. Genet. 48, 74–78 (2016).
Teh, M. R., Frost, J. N., Armitage, A. E. & Drakesmith, H. Analysis of iron and iron-interacting protein dynamics during T-cell activation. Front. Immunol 12, 714613 (2021).
Sivaprakasam, S. et al. Hereditary hemochromatosis promotes colitis and colon cancer and causes bacterial dysbiosis in mice. Biochem. J. 477, 3867–3883 (2020).
Buhnik-Rosenblau, K., Moshe-Belizowski, S., Danin-Poleg, Y. & Meyron-Holtz, E. G. Genetic modification of iron metabolism in mice affects the gut microbiota. BioMetals 25, 883–892 (2012).
Parmanand, B. et al. Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis. JHEP Rep. 2, 100154 (2020).
Effenberger-Neidnicht, K. & Hartmann, M. Mechanisms of hemolysis during sepsis. Inflammation 41, 1569–1581 (2018).
White, N. J. Anaemia and malaria. Malar. J. 17, 371 (2018).
Choi, G. et al. The transcriptional regulator IscR integrates host-derived nitrosative stress and iron starvation in activation of the vvhBA operon in Vibrio vulnificus. J. Biol. Chem. 295, 5350–5361 (2020).
Stefanova, D. et al. Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non–transferrin-bound iron. Blood 130, 245–257 (2017).
Malerba, M. et al. Epidermal hepcidin is required for neutrophil response to bacterial infection. J. Clin. Invest. 130, 329–334 (2017).
Michels, K., Nemeth, E., Ganz, T. & Mehrad, B. Hepcidin and host defense against infectious diseases. PLoS Pathog. 11, e1004998 (2015).
Taylor, M. et al. Hypoxia-Inducible Factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 140, 2044–2055 (2011).
Singhal, R. & Shah, Y. M. Oxygen battle in the gut: hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine. J. Biol. Chem. 295, 10493–10505 (2020).
Elinav, E., Henao-Mejia, J., Strowig, T. & Flavell, R. NLRP6 and dysbiosis: avoiding the luring attraction of over-simplification. Immunity 48, 603–604 (2018).
Gamage, S. M. K., Dissabandara, L., Lam, A. K.-Y. & Gopalan, V. The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma. Crit. Rev. Oncol. Hematol. 126, 121–128 (2018).
Seiwert, N., Heylmann, D., Hasselwander, S. & Fahrer, J. Mechanism of colorectal carcinogenesis triggered by heme iron from red meat. Biochim. Biophys. Acta Rev. Cancer 1873, 188334 (2020).
Ijssennagger, N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl Acad. Sci. USA 112, 10038–10043 (2015).
Huang, P. & Liu, Y. A reasonable diet promotes balance of intestinal microbiota: prevention of precolorectal cancer. BioMed. Res. Int. 2019, e3405278 (2019).
Arima, K. et al. Western-style diet, pks island-carrying Escherichia coli, and colorectal cancer: analyses from two large prospective cohort studies. Gastroenterology 163, 862–874 (2022).
Cougnoux, A. et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63, 1932–1942 (2014).
Boleij, A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208–215 (2015).
Tronnet, S. et al. High iron supply inhibits the synthesis of the genotoxin colibactin by pathogenic Escherichia coli through a non-canonical Fur/RyhB-mediated pathway. Pathog. Dis. 75, ftx066 (2017).
Brookes, M. J. et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55, 1449–1460 (2006).
Xue, X. et al. Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metab. 24, 447–461 (2016).
Schwartz, A. J. et al. Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells. Nat. Metab. 3, 969–982 (2021).
Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845.e20 (2019).
Sharma, G. et al. A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron. Nat. Immunol. 25, 790–801 (2024).
Cheung, Y. B. et al. Gut microbiota in Malawian infants in a nutritional supplementation trial. Trop. Med. Int. Health 21, 283–290 (2016).
Takagi, T. et al. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. J. Clin. Biochem. Nutr. 62, 100–105 (2018).
Jørgensen, J. T. Twenty years with personalized medicine: past, present and future of individualized pharmacotherapy. Oncologist 24, e432–e440 (2019).
Brugiroux, S. et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat. Microbiol. 2, 16215 (2016).
Cheng, A. G. et al. Design, construction, and in vivo augmentation of a complex gut microbiome. Cell 185, 3617–3636.e19 (2022).
Jennings, S. A. V. & Clavel, T. Synthetic communities of gut microbes for basic research and translational approaches in animal health and nutrition. Annu. Rev. Anim. Biosci. 12, 283–300 (2024).
Britton, G. J. et al. Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORγt+ regulatory T cells and exacerbate colitis in mice. Immunity 50, 212–224.e4 (2019).
Culp, E. J., Nelson, N. T., Verdegaal, A. A. & Goodman, A. L. Microbial transformation of dietary xenobiotics shapes gut microbiome composition. Cell 187, 6327–6345.e20 (2024).
Ratiner, K., Ciocan, D., Abdeen, S. K. & Elinav, E. Utilization of the microbiome in personalized medicine. Nat. Rev. Microbiol. 22, 291–308 (2024).
Kroot, J. J., Tjalsma, H., Fleming, R. E. & Swinkels, D. W. Hepcidin in human iron disorders: diagnostic implications. Clin. Chem. 57, 1650–1669 (2011).
Skolmowska, D. & Głąbska, D. Analysis of heme and non-heme iron intake and iron dietary sources in adolescent menstruating females in a national Polish sample. Nutrients 11, 1049 (2019).
Liu, Z. et al. Role of ROS and nutritional antioxidants in human diseases. Front. Physiol. 9, 477 (2018).
Haider, L. M., Schwingshackl, L., Hoffmann, G. & Ekmekcioglu, C. The effect of vegetarian diets on iron status in adults: a systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 58, 1359–1374 (2018).
Hunt, J. R. Bioavailability of iron, zinc and other trace minerals from vegetarian diets. Am. J. Clin. Nutr. 78, 633S–639S (2003).
Pawlak, R., Berger, J. & Hines, I. Iron status of vegetarian adults: a review of literature. Am. J. Lifestyle Med. 12, 486–498 (2016).
Teucher, B., Olivares, M. & Cori, H. Enhancers of iron absorption: ascorbic acid and other organic acids. Int. J. Vitam. Nutr. Res. 74, 403–419 (2004).
Lane, D. J. R. & Richardson, D. R. The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption! Free Radic. Biol. Med. 75, 69–83 (2014).
Porres, J. M., Etcheverry, P., Miller, D. D. & Lei, X. G. Phytase and citric acid supplementation in whole-wheat bread improves phytate-phosphorus release and iron dialyzability. J. Food Sci. 66, 614–619 (2001).
Palika, R. et al. Citric acid mediates the iron absorption from low molecular weight human milk fractions. J. Agric. Food Chem. 61, 11151–11157 (2013).
Pham, V. T. et al. Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome-a pilot study. Gut Microbes 13, 1875774 (2021).
Kumar, V., Sinha, A. K., Makkar, H. P. S. & Becker, K. Dietary roles of phytate and phytase in human nutrition: a review. Food Chem. 120, 945–959 (2010).
Scarano, A. et al. The chelating ability of plant polyphenols can affect iron homeostasis and gut microbiota. Antioxidants 12, 630 (2023).
Jiao, Y. et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 113, 462–469 (2009).
Gibson, R. S. The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based dietary requirement estimates. Food Nutr. Bull. 28, S77–S100 (2007).
Lam, J. R., Schneider, J. L., Quesenberry, C. P. & Corley, D. A. Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology 152, 821–829.e1 (2017).
Tran-Duy, A. et al. Use of proton pump inhibitors and risk of iron deficiency: a population-based case–control study. J. Intern. Med. 285, 205–214 (2019).
Hamano, H. et al. Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway. Toxicol. Lett. 318, 86–91 (2020).
Dignass, A. U. et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J. Crohns Colitis 9, 211–222 (2015).
Leonard, J., Marshall, J. K. & Moayyedi, P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol. 102, 2047 (2007).
McDonald, E. G., Milligan, J., Frenette, C. & Lee, T. C. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern. Med. 175, 784–791 (2015).
Watkins, D. W., Khalafi, R., Cassidy, M. M. & Vahouny, G. V. Alterations in calcium, magnesium, iron and zinc metabolism by dietary cholestyramine. Dig. Dis. Sci. 30, 477–482 (1985).
James, M. W., Chen, C.-M., Goddard, W. P., Scott, B. B. & Goddard, A. F. Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia. Eur. J. Gastroenterol. Hepatol. 17, 1197–1203 (2005).
Sirbu, O. et al. The influence of cardiovascular medications on iron metabolism in patients with heart failure. Medicina 55, 329 (2019).
McClorry, S., Ji, P., Parenti, M. G. & Slupsky, C. M. Antibiotics augment the impact of iron deficiency on metabolism in a piglet model. J. Nutr. Biochem. 119, 109405 (2023).
